Biotron Limited
BITRF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.04 | -0.08 | 0.31 |
| FCF Yield | -6.67% | 3.09% | -0.62% | -3.69% |
| EV / EBITDA | -14.44 | 21.06 | -22.88 | -64.86 |
| Quality | ||||
| ROIC | -187.68% | 151.85% | 900.82% | -72.33% |
| Gross Margin | 100.00% | 100.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 1.04 | 0.70 | 0.15 | 2.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 23.45% | 100.92% | 27.79% | 53.13% |
| Free Cash Flow Growth | -316.96% | 258.19% | 90.57% | -32.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.90 | -1.25 | 0.18 | 0.51 |
| Interest Coverage | 0.00 | 1,725.33 | -2,005.71 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -683.57 | 0.00 |